14:00 - 17:20
- 非上市公司路演专场
- Non-Listed Company Roadshow
主持人
- 贺菊颖 , 中信建投证券医药行业首席分析师
- HE Juying , Head of Healthcare Equity Research at China Securities
14:00 - 14:20 - 项目1
- Project 1
- 全球首创24价双载体蛋白肺炎结合疫苗的开发和产业化
- Development of A Novel 24 Valent Pneumococcal Conjugate Vaccine with Dual Carrier Proteins Against Pneumococcal Diseases
- 祝先潮 上海瑞宙生物科技有限公司创始人、总经理、首席科学官
- Jeff ZHU , Founder, CEO, CSO, Shanghai Reinovax Biologics Co., Ltd.
14:20 - 14:40 - 项目2
- Project 2
- 成都柏奥特克——聚焦成熟大苗市场的新一代疫苗开发领军企业
- Chengdu Boaovax - A New Generation of Vaccine Developer Focusing on the Mature Vaccine Market
- 梁智杰 成都柏奥特克生物科技股份有限公司总经理
- Colin LIANG , CEO, BOAOVAX INC.
14:40 - 15:00 - 项目3
- Project 3
- 溶瘤病毒OH2注射液激活淋巴细胞治疗恶性胸腹水转化研究
- Oncolytic Virus OH2 Injection Activates Lymphocytes to Treat Malignant Pleural and Ascites Fluid Conversion Research
- 汪洋 武汉滨会生物科技股份有限公司副总经理
- WANG Yang , Vice General Manager, Binhui Biopharmaceutical Co., Ltd.
15:00 - 15:20 - 项目4
- Project 4
- 下一代生物载体递送平台
- Next-Generation Biological Vector Delivery Platform
- 张玺 深圳市亦诺微医药科技有限公司资本市场副总裁
- ZHANG Xi , VP, ImmVira
15:20 - 15:40 - 项目5
- Project 5
- AI驱动药物递送和药物发现
- AI-Driven Drug Delivery and Drug Discovery
- 王文首 剂泰医药联合创始人&首席运营官
- WANG Wenshou , Co-Founder&COO, METiS Pharmaceuticals
15:40 - 16:00 - 项目6
- Project 6
- 实体肿瘤细胞药物开发的天科雅方案
- TCRCURE Solutions for Solid Tumor
- 彭玲 天科雅临床副总裁
- Lynn PENG , Clinical VP, TCRCURE
16:00 - 16:20 - 项目7
- Project 7
- MetCura——致力于为全球抗生素耐药问题提供差异化解决方案
- MetCura—Dedicated to Providing Differentiated Solutions to the Global Antibiotic Resistance Problem
- 邓一军 MetCura首席科学官
- DENG Yijun , CSO & Co-Founder, MetCura Pharmaceuticals Inc.
16:20 - 16:40 - 项目8
- Project 8
- 浙江海昶生物医药技术有限公司——自主知识产权QTsome递送技术平台
- Zhejiang Haichang Biotech Co., Ltd.-Independent Intellectual Property Rights of the QTsome Delivery Technology Platform
- 李剑光 浙江海昶生物医药技术有限公司首席科学家
- Robert J. Lee , Chief Scientific Officer, Zhejiang Haichang Biotech Co., Ltd.
16:40 - 17:00 - 项目9
- Project 9
- 诺纳生物:依托核心技术平台,引领全球下一代生物药创新
- Nona Bioscience: Leveraging Industry Leading Platforms to Empower Global Biotherapeutic Innovation
- 何云 诺纳生物首席技术官
- HE Yun , CTO, Nona Biosciences
17:00 - 17:20 - 项目10
- Project 10
- 基于AIGC新型选择性BTK和JAK3双靶抑制剂候选物WJ1113的发现与生物活性研究
- Discovery and Biological Evaluation of Selective BTK and JAK3 Dual-Target Inhibitor Candidate WJ1113 based on AIGC Strategy
- 汪小涧 中国医学科学院药物研究所研究员
- WANG Xiaojian , Professor, the Institute of Materia Medica Chinese Academy of Medical Science